Daniel Farnum
Corporate Officer/Principal bei Humboldt Medical Group, Inc.
Profil
Daniel Farnum is currently a Co-Owner at Humboldt Medical Group, Inc. He was previously a Director at Iris BioTechnologies, Inc. Farnum received his undergraduate and doctorate degrees from The University of California, San Francisco.
Aktive Positionen von Daniel Farnum
| Unternehmen | Position | Beginn |
|---|---|---|
| Humboldt Medical Group, Inc. | Corporate Officer/Principal | 02.05.2011 |
Ehemalige bekannte Positionen von Daniel Farnum
| Unternehmen | Position | Ende |
|---|---|---|
| IRIS BIOTECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Daniel Farnum
| The University of California, San Francisco | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Iris BioTechnologies, Inc.
 Iris BioTechnologies, Inc. Medical SpecialtiesHealth Technology Iris Biotechnologies, Inc. is life sciences company focused on health care. It offers the best approach to the treatment of cancer and other diseases through actionable integration of molecular profiling in the clinical decision-making process. The Iris Nano-Biochip product pipeline include CancerChip, PrenatalChip, Integrated Blood Test, IVF applications, NeuroChip, MetabolicChip, CardioChip, and Chips for veterinary, agricultural, environmental, and other applications. The company was founded by Simon Chin on February 16, 1999 and is headquartered in Santa Clara, CA. | Health Technology |
| Humboldt Medical Group, Inc. |
